MediPharm Labs Corp (OTCPK:MEDIF)

Q3 2025 Medipharm Labs Corp Earnings Call Transcript

Nov 13, 2025 / 03:00 PM GMT

Release Date Price: $0.0491 (-5.76%)

Transcript

Key Points

Positve

MediPharm Labs Corp (MEDIF) achieved a 17% year-over-year revenue growth in Q3 2025, demonstrating effective strategic execution.
International medical cannabis revenue grew by 83% compared to the prior year, now representing 56% of total revenues.
The company holds a unique suite of pharmaceutical licenses, including an FDA-inspected facility, enabling operations in complex regulatory environments.
MediPharm Labs Corp (MEDIF) has virtually no debt and reduced operating expenses by 19% year over year, indicating strong financial stability.
The company is expanding its product portfolio with innovative offerings like metered dose inhalers, which are expected to improve margins and meet consumer demand for smoke-free options.

Negative

Gross margin decreased from 39% in Q1 to 22% in Q3, attributed to product mix and plant shutdowns.
Despite revenue growth, the company reported an adjusted EBITDA loss of 1.1 million in Q3.
Pricing pressure remains a challenge, particularly in international markets, affecting profitability.
The Canadian medical cannabis revenue decreased compared to the prior year, indicating challenges in the domestic market.
There is uncertainty regarding the potential rescheduling of cannabis in the US, which could impact future market opportunities.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LABS.TO - Medipharm Labs Corp
Q3 2025 Medipharm Labs Corp Earnings Call
Nov 13, 2025 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, this is the operator. Today's conference is scheduled to begin momentarily. Until that time, your lines will again be placed on music hold.

Thank you for your patience.

Thank you for standing by and welcome to the MetaFarm Labs conference call to discuss this 3rd quarter 2025 results.

Our speakers on today's call are David Piddock, President and Chief Executive Officer, and Craig Hunter, Chief Financial Officer.

As a reminder, all participants are in listen-only mode, and the conference is being recorded. After management's presentation, we will take questions from the analyst community on the telephone and then take written questions through the Q&A feature on the webcast

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.